Literature DB >> 8543691

Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo.

K Kameyama1, C Sakai, S Kondoh, K Yonemoto, S Nishiyama, M Tagawa, T Murata, T Ohnuma, J Quigley, A Dorsky, D Bucks, K Blanock.   

Abstract

BACKGROUND: An inhibitory effect of ascorbic acid (AsA) on melanogenesis has been described. However, AsA is quickly oxidized and decomposed in aqueous solution and thus is not generally useful as a depigmenting agent.
OBJECTIVE: Our purpose was to examine the effect on pigmentation of magnesium-L-ascorbyl-2-phosphate (VC-PMG), a stable derivative of AsA.
METHODS: Percutaneous absorption of VC-PMG was examined in dermatomed human skin, and its effect on melanin production by mammalian tyrosinase and human melanoma cells in culture was also measured. A 10% VC-PMG cream was applied to the patients.
RESULTS: VC-PMG suppressed melanin formation by tyrosinase and melanoma cells. In situ experiments demonstrated that VC-PMG cream was absorbed into the epidermis and that 1.6% remained 48 hours after application. The lightening effect was significant in 19 of 34 patients with chloasma or senile freckles and in 3 of 25 patients with normal skin.
CONCLUSION: VC-PMG is effective in reducing skin hyperpigmentation in some patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8543691     DOI: 10.1016/s0190-9622(96)90830-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

Review 2.  [Topical treatment of skin aging].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

3.  A new approach for increasing ascorbyl palmitate stability by addition of non-irritant co-antioxidant.

Authors:  Mirjam Gosenca; Aleš Obreza; Slavko Pečar; Mirjana Gašperlin
Journal:  AAPS PharmSciTech       Date:  2010-09-16       Impact factor: 3.246

Review 4.  Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders.

Authors:  Hideya Ando; Mary S Matsui; Masamitsu Ichihashi
Journal:  Int J Mol Sci       Date:  2010-06-18       Impact factor: 5.923

5.  "Multi Light and Drugs": a new technique to treat face photoaging. Comparative study with photorejuvenation.

Authors:  Paolo Mezzana
Journal:  Lasers Med Sci       Date:  2007-05-10       Impact factor: 3.161

Review 6.  Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications.

Authors:  Firas Al-Niaimi; Nicole Yi Zhen Chiang
Journal:  J Clin Aesthet Dermatol       Date:  2017-07-01

7.  Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers.

Authors:  Sorgan Shou-Ku Tai; Ching-Gong Lin; Mon-Han Wu; Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

8.  Topical treatment of melasma.

Authors:  Debabrata Bandyopadhyay
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

Review 9.  Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration.

Authors:  Jody P Ebanks; R Randall Wickett; Raymond E Boissy
Journal:  Int J Mol Sci       Date:  2009-09-15       Impact factor: 6.208

10.  Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.

Authors:  Surabhi Dayal; Priyadarshini Sahu; Manoj Yadav; V K Jain
Journal:  J Clin Diagn Res       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.